3 Results for "

Milciclib

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "Milciclib" in MCE Product Catalog:

7
7 Cited Publications
Cat. No.: HY-10424
CAS No.: 802539-81-7
Purity:  99.90%
Synonyms: PHA-848125
Target:  

CDK Autophagy

Research Areas:  

Cancer

Milciclib (PHA-848125) is a potent, ATP-competitive and dual inhibitor of CDK and Tropomyosin receptor kinase (TRK), with IC50s of 45, 150, 160, 363, 398 nM and 53 nM for cyclin A/CDK2, cyclin H/CDK7, cyclin D1/CDK4, cyclin E/CDK2, cyclin B/CDK1 and TRKA, respectively.
loading...
    loading...
Cat. No.: HY-10424A
CAS No.: 1253645-38-3
Synonyms: PHA-848125 maleate
Target:  

Ser/Thr Kinase

Research Areas:  

Cancer

Milciclib (PHA-848125) maleate is a cyclin-dependent kinase inhibitor that impairs melanoma cell growth and modulates gene expression involved in cell cycle regulation. Milciclib maleate has been shown to significantly affect the expression of various genes, including down-regulating PTTG1, contributing to its antiproliferative activity. Milciclib maleate enhances sensitivity to treatment in p53 mutated melanoma cells when combined with PTTG1 silencing.
loading...
    loading...
Cat. No.: HY-10424R
CAS No.: 802539-81-7
Synonyms: PHA-848125 (Standard)
Research Areas:  

Cancer

Milciclib (Standard) is the analytical standard of Milciclib. This product is intended for research and analytical applications. Milciclib (PHA-848125) is a potent, ATP-competitive and dual inhibitor of CDK and Tropomyosin receptor kinase (TRK), with IC50s of 45, 150, 160, 363, 398 nM and 53 nM for cyclin A/CDK2, cyclin H/CDK7, cyclin D1/CDK4, cyclin E/CDK2, cyclin B/CDK1 and TRKA, respectively.
loading...
    loading...